BSM
Earnings company data as of 8:59 AM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 2 Nov | EPS | 0.21 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by BSM's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $2.4M bought by 2 insiders
- $28.2M sold by 2 insiders outside a trading plan
- $1.3M sold by 1 insider under 10b5-1 plans
-
James Whitehead DirectorSale$28.1M 2,127,105 shares at $13.21 77% of stakeTraded Aug 6 Filed Aug 10
-
D Mark DeWalch DirectorBuy$985K 72,726 shares at $13.55 +13% to stakeTraded May 29–Jun 1 Filed Jun 2
-
D Mark DeWalch DirectorBuy$497K 37,650 shares at $13.21 +9.6% to stakeTraded May 28 Filed May 28
-
Thomas L Carter Jr. ChairBuy$15K 1,120 shares at $13.50 +<0.1% to stakeTraded May 13 Filed May 14
-
Ashley J Longmaid DirectorSale$150K 11,128 shares at $13.45 7.5% of stakeTraded May 12 Filed May 13
-
Thomas L Carter Jr. ChairBuy$909K 67,758 shares at $13.42 +1.9% to stakeTraded May 8–12 Filed May 12
-
Luke Stevens Putman SVP, General Counsel, and SecPlanned sale$425K 29,386 shares at $14.45 3.9% of stakeTraded Apr 6 Filed May 6
-
Luke Stevens Putman SVP, General Counsel, and SecPlanned sale$404K 29,386 shares at $13.75 4% of stakeTraded May 5 Filed May 6
-
Luke Stevens Putman SVP, General Counsel, and SecPlanned sale$462K 30,276 shares at $15.25 3.8% of stakeTraded Mar 5 Filed May 6
Also filed in the last 12 months, not counted as buying or selling: 39 stock grants, 11 share withholdings for taxes, 1 gift, and 1 other transaction.
SEC filings
Recent issuer filings from EDGAR, 8 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.